Sunesis Pharmaceuticals
| Region | Nordamerika |
| ISIN | US8673288747 |
| Sektor | Biotechnologie |
| Website | https://www.sunesis.com/ |
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.
| Titel | Autor | Datum |
|---|---|---|
|
Risikoarmes "Peak Play" mit Multibagger-Potenzial
|
sharedeals | vor ungefähr 3 Monaten |
| Titel | Datum |
|---|---|
| Sunesis Pharmaceuticals EPS beats by $0.06 | vor ungefähr 2 Monaten |
| Sunesis Pharmaceuticals, Inc.: Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent Highlights | vor ungefähr 2 Monaten |
| Pre-market Movers In Healthcare Sector: MGEN, EQ, SNSS, IPHA, BLCM, Axovant … | vor ungefähr 3 Monaten |
| Sunesis Pharmaceuticals, Inc.: Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symp... | vor ungefähr 4 Monaten |
| SUNESIS PHARMACEUTICALS INC - 8-K, Current Report | vor ungefähr 4 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Suedzucker (1 Artikel) | |
| Stockholm IT Ventures AB (1 Artikel) | |
| Tahoe Resources (1 Artikel) | |
| Telit Communications (3 Artikel) | |
| Alle anzeigen | |